5-HT(1B) receptor-mediated contractions in human temporal artery: Evidence from selective antagonists and 5-HT receptor mRNA expression

British Journal of Pharmacology

Volumn 124, Issue 7, 1998, Pages 1345-1354

  Verheggen, R ^a   Hundeshagen, A G ^a   Brown, A M ^b   Schindler, M ^b   Kaumann, A J ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b GLAXOSMITHKLINE   (United Kingdom)

^c BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

5 HT receptor mRNA; 5 HT(1B) receptor; 5 HT(2A) receptors; 5 Hydroxytryptamine; BRL 15572; Contraction of human temporal artery; SB 224289; Sumatriptan

Indexed keywords

2,3,6,7 TETRAHYDRO 1' METHYL 5 [2' METHYL 4'[(5 METHYL 1,2,4 OXADIAZOL 3 YL)BIPHENYL 4 YL]CARBONYL]FURO[2,3 F]INDOLE 3 SPIRO 4' PIPERIDINE OXALATE; 3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; KETANSERIN; MESSENGER RNA; SEROTONIN; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D ANTAGONIST; SEROTONIN 1D RECEPTOR; SUMATRIPTAN; UNCLASSIFIED DRUG; BIPHENYL DERIVATIVE; HTR1B PROTEIN, HUMAN; PIPERAZINE DERIVATIVE; PIPERIDONE DERIVATIVE; PRIMER DNA; SB 22489G; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SPIRO COMPOUND;

ADOLESCENT; AGED; ARTERY CONSTRICTION; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPORAL ARTERY; ADULT; DRUG EFFECT; GENETICS; IN VITRO STUDY; MIDDLE AGED; MUSCLE CONTRACTION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BIPHENYL COMPOUNDS; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; PIPERAZINES; PIPERIDONES; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; RNA, MESSENGER; SEROTONIN ANTAGONISTS; SPIRO COMPOUNDS; SUMATRIPTAN; TEMPORAL ARTERIES;

EID: 0031595228     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701929     Document Type: Article

References (28)

1. 7) positively linked to adenylate cyclase. J. Biol. Chem., 268, 23422-23426.
2. BOUCHELET, I., CASE, B. & HAMEL, E. (1996a). Expression of mRNA for serotonin (5-HT) receptors in human coronary arteries. Proceedings of the 26th Annual Meeting of the Society of Neuroscience. Washington, November 16-21, 1578.
3. BOUCHELET, I., COHEN, Z., CASE, B., SEGUELA, P. & HAMEL, E. (1996b). Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol. Pharmacol., 50, 219-223.
4. BROWNLEE, K.A. (1965). Statistical Theory and Methodology in Science and Engineering. Second Edition. New York: John Wiley.
5. CHOMCZYSKI, P. & SACCHI, N. (1987). Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
6. 4 receptors. Br. J. Pharmacol., 107, 591-596.
7. FOZARD, J.R. & KALKMAN, H (1994). 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 225-229.
8. 2-adrenoceptor on ligand affinity in transgenic mice. Mol. Pharmacol., 52, 187-94.
9. 1Dβ receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol., 44, 242-246.
10. 1D receptor subtypes. Trends Pharmacol. Sci., 17, 103-105.
11. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). VII International Union of Pharmacology. Classification of Receptors for 5-Hydroxytryptamine (Serotonin). Pharmacol. Rev., 46, 157-203.
12. 1Dβ receptors. Circulation, 90, 1141-1153.
13. KAUMANN, A.J., PARSONS, A.A. & BROWN, A.M. (1993). Human arterial constrictor serotonin receptors. Cardiovasc. Res., 27, 2094-2103.
14. 1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia, 17, 833-842.
15. 1Dα receptors in human atrium. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 272-280.
16. 1D binding sites. Eur. J. Pharmacol., 163, 133-136.
17. 1D receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 312-320.
18. 1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea pig. Neuropharmacology, 36, 549-557.
19. SAMBROOK, J., FRITSCH, E.F. & MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edition. Cold Spring Harbor, New York: Cold Spring Harbor Lab.
20. 1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto-and heteroreceptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 321-327.
21. 2B receptors: an early step in the generation of migraine headache? Eur. J. Neurosci., 8, 959-967.
22. 7 receptors in human vascular smooth muscle cells. Br. J. Pharmacol., 117, 993-994.
23. SHAPIRO, S.S., WILK, M.B. & CHEN, H.J. (1968). A comparative study of various tests of normality. J. Am. Statistical Assn. 63, 1343-1372.
24. SIEBERT. P.D. & CHENCHIK, A. (1993). Modified guanidinium thiocyanate-phenol-chloroform RNA-extraction method which greatly reduces DNA contamination. Nucleic Acids Res., 21, 2019-2020.
25. 1A receptor genes. Eur. J. Pharmacol., 227, 153-162.
26. 7 receptor subtype. Br. J. Pharmacol., 118, 1421-1428.
27. ULLMER, C., SCHMUCK, K., KALKMAN, H.O. & LÜBBERT, H. (1995). Expression of serotonin receptor mRNAs in blood vessels. FEBS Letts, 370, 215-221.
28. 2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs. Br. J. Pharmacol., 117, 283-292.